Tradestie Institutional Equity Comparison Engine

RBOT.WS vs ALGN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ALGN Overall Edge

ALGN Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Align Technology Inc (ALGN) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RBOT.WS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ALGN at 12.6x Forward P/E and 19.6% operating margin (+1.9% YoY). In options structure, RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ALGN sits in SURGE (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ALGN
RBOT.WS N/M vs ALGN 12.6x Fwd P/E
Growth & Margin Winner ALGN
Op Margin N/A vs 19.6% ยท YoY N/A vs +1.9%
Momentum & Technical Winner ALGN
1Y -67.2% vs +16.1% ยท 52W Pos 0% vs 34%
Options & Structure Winner ALGN
UNCLASSIFIED (N/A IV) vs SURGE (10th %ile IV)
RBOT.WS NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap N/A
1M Return -67.2%
1Y Return -67.2%
Forward P/E N/M
Unified AI Score
50.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0
ALGN NASDAQ
Align Technology Inc
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$155.17
-2.82% 1D
Market Cap $11.3B
1M Return -0.22%
1Y Return +16.08%
Forward P/E 12.6x
Unified AI Score
40.4 / 100 SELL
Tech 20.0 Fund 47.0 Flow 68.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RBOT.WS -67.2% ALGN +16.08% Spread: +89.69 pp (ALGN Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RBOT.WS TTM Op. Margin: N/A ALGN TTM Op. Margin: 19.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RBOT.WS vs ALGN. Trailing 12-month operating profitability (RBOT.WS N/A vs ALGN 19.6%) and valuation multiples (RBOT.WS N/M vs ALGN 12.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RBOT.WS (1) vs ALGN (9)
Institutional Metric RBOT.WS ALGN Criterion Row Winner
Market Capitalization Scale N/A $11.3B Larger Scale ALGN
Trailing P/E Ratio Valuation N/M 23.3x Lower Multiple ALGN
Forward P/E Ratio Valuation N/M 12.6x Lower Multiple ALGN
Revenue Growth (YoY) Growth N/A +1.9% Higher Growth ALGN
Operating Margin (TTM) Profitability N/A 19.6% Higher Margin ALGN
Net Profit Margin Profitability N/A 11.8% Higher Margin ALGN
Return on Equity (ROE) Capital Efficiency N/A 11.9% Higher ROE ALGN
52-Week Range Position Momentum 0% ($0โ€“$0) 34% ($132โ€“$200) Stronger Trend ALGN
Beta / 30D Volatility Risk Regime N/A 1.15ฮฒ ยท 46% Vol Lower Realized Risk ALGN
Unified Institutional Score Composite Signal 50.1 / 100 (HOLD) 40.4 / 100 (SELL) Higher Composite RBOT.WS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RBOT.WS vs ALGN Buy Guide
RBOT.WS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RBOT.WS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ALGN SURGE
9d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live ALGN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RBOT.WS nor ALGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.